An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway–Impact on radiologist person-years, costs and effects
- 9 September 2025
- journal article
- Published by SAGE Publications in Journal of Medical Screening
- Vol. 33 (1) , 38-47
Abstract
Objective: To study the implications of implementing artificial intelligence (AI) as a decision support tool in the Norwegian breast cancer screening program concerning cost-effectiveness and time savings for radiologists. Methods: In a decision tree model using recent data from AI vendors and the Cancer Registry of Norway, and assuming equal effectiveness of radiologists plus AI compared to standard practice, we simulated costs, effects and radiologist person-years over the next 20 years under different scenarios: 1) Assuming a €1 additional running cost of AI instead of the €3 assumed in the base case, 2) varying the AI-score thresholds for single vs. double readings, 3) varying the consensus and recall rates, and 4) reductions in the interval cancer rate compared to standard practice. Results: AI was unlikely to be cost-effective, even when only one radiologist was used alongside AI for all screening exams. This also applied when assuming a 10% reduction in the consensus and recall rates. However, there was a 30–50% reduction in the radiologists’ screen-reading volume. Assuming an additional running cost of €1 for AI, the costs were comparable, with similar probabilities of cost-effectiveness for AI and standard practice. Assuming a 5% reduction in the interval cancer rate, AI proved to be cost-effective across all willingness-to-pay values. Conclusions: AI may be cost-effective if the interval cancer rate is reduced by 5% or more, or if its additional cost is €1 per screening exam. Despite a substantial reduction in screening volume, this remains modest relative to the total radiologist person-years available within breast centers, accounting for only 3–4% of person-years.Keywords
This publication has 43 references indexed in Scilit:
- Cost-Effectiveness of AI for Risk-Stratified Breast Cancer ScreeningJAMA Network Open, 2024
- Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer casesEuropean Radiology, 2023
- Breast cancer screening and overdiagnosisInternational Journal of Cancer, 2021
- Can artificial intelligence reduce the interval cancer rate in mammography screening?European Radiology, 2021
- Identifying normal mammograms in a large screening population using artificial intelligenceEuropean Radiology, 2020
- External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening MammogramsJAMA Oncology, 2020
- Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility studyEuropean Radiology, 2019
- A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trialEuropean Radiology, 2018
- Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided DetectionJAMA Internal Medicine, 2015
- Breast cancer mortality in participants of the Norwegian Breast Cancer Screening ProgramCancer, 2013